A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Ryan Reed to Compete for GMS Racing at Darlington Raceway

Ryan Reed will pilot the No. 24 Tandem Diabetes Care Chevrolet Silverado at Darlington Raceway this Friday reports GMS Racing officials.

Ryan Reed said, “I’m so excited and I can’t thank Chevy and everyone at GMS, Mike (Beam) and Maury (Gallagher), enough for the opportunity.” He added, “It is awesome to see a new partner come into the sport with Tandem Diabetes Care. I use their t:slim X2 insulin pump to help manage my type 1 diabetes and their advanced Control-IQ technology has improved my health overall. It’s incredible to be able to represent them on the track and have my daily life changed by their product.”

A new partner in NASCAR, Tandem Diabetes Care is dedicated to making the lives of people with diabetes better through relentless innovation and revolutionary customer experience.

“We are thrilled that Ryan (Reed) is experiencing the benefits of the t:slim X2 pump with Control-IQ technology, and couldn’t be more excited to support him in following his passion,” said John Sheridan, President and CEO, Tandem Diabetes Care. “We’re constantly hearing from customers about how our technology is changing lives and we believe that Ryan getting behind the wheel this weekend is yet another example of these positive outcomes.”

“We’re very grateful to have talented drivers like Ryan (Reed) to be able to step up and compete for us,” said Mike Beam, President of GMS Racing. “We’re thankful for him and his partner Tandem Diabetes Care for coming on board with us for Darlington.”

The No. 24 Tandem Diabetes Care Chevrolet Silverado will make it’s on-track debut in the LIftKits4Less.com 200 at Darlington Raceway on Friday, May 7. The race will be broadcast live on FS1 and MRN.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy